• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国的癌症筛查:现状、挑战和建议。

Cancer screening in China: The current status, challenges, and suggestions.

机构信息

National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.

National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.

出版信息

Cancer Lett. 2021 May 28;506:120-127. doi: 10.1016/j.canlet.2021.02.017. Epub 2021 Mar 6.

DOI:10.1016/j.canlet.2021.02.017
PMID:33684533
Abstract

Substantial progress has been made in cancer screening in China due to the substantial efforts of all levels of the government. Four large-scale population-based screening programs have been launched since 2005. In these programs, individuals at high risk for the most common types of cancer are screened with no cost. However, there are still wide gaps remaining between the cancer screening objectives and reality. In this review, we summarize the current status of cancer screening, identify the major achievements and challenges of cancer screening, and propose some suggested improvements based on the existing evidence. The main challenges include low participation rates, the uneven distribution of medical sources, inadequate funding, and insufficient screening quality. Some suggestions that should be considered to improve the quality of cancer screening include advertising to increase awareness, providing universal training of staff involved in screening programs, optimizing the definition of high-risk populations, integrating new technologies into cancer screening programs, and implementing appropriate management measures among individuals with positive screening results.

摘要

由于各级政府的大力投入,中国的癌症筛查工作取得了实质性进展。自 2005 年以来,已经启动了四个大型基于人群的筛查项目。在这些项目中,高风险人群可以免费进行最常见类型癌症的筛查。然而,癌症筛查目标与现实之间仍存在很大差距。在这篇综述中,我们总结了癌症筛查的现状,确定了癌症筛查的主要成就和挑战,并根据现有证据提出了一些改进建议。主要挑战包括参与率低、医疗资源分布不均、资金不足和筛查质量不足。为了提高癌症筛查质量,应该考虑一些建议,包括宣传提高认识、对参与筛查项目的人员进行普遍培训、优化高危人群的定义、将新技术纳入癌症筛查项目以及对筛查结果阳性的个体实施适当的管理措施。

相似文献

1
Cancer screening in China: The current status, challenges, and suggestions.中国的癌症筛查:现状、挑战和建议。
Cancer Lett. 2021 May 28;506:120-127. doi: 10.1016/j.canlet.2021.02.017. Epub 2021 Mar 6.
2
Implementation of cervical cancer screening and prevention in China--challenges and reality.中国宫颈癌筛查与预防的实施——挑战与现实
Jpn J Clin Oncol. 2015 Jan;45(1):7-11. doi: 10.1093/jjco/hyu188. Epub 2014 Nov 14.
3
Patterns of cancer screening, incidence and treatment disparities in China: protocol for a population-based study.中国癌症筛查、发病率及治疗差异模式:一项基于人群研究的方案
BMJ Open. 2016 Aug 4;6(8):e012028. doi: 10.1136/bmjopen-2016-012028.
4
Future Perspectives in Cancer Screening and Early Detection.癌症筛查与早期检测的未来展望
Semin Oncol Nurs. 2017 May;33(2):219-222. doi: 10.1016/j.soncn.2017.02.010. Epub 2017 Mar 27.
5
[Access to liver cancer screening and surveillance in populations in China: an exploratory analysis].[中国人群肝癌筛查与监测的可及性:一项探索性分析]
Zhonghua Liu Xing Bing Xue Za Zhi. 2022 Jun 10;43(6):906-914. doi: 10.3760/cma.j.cn112338-20211112-00879.
6
Improving cancer screening programs.改善癌症筛查项目。
Science. 2020 Jan 10;367(6474):143-144. doi: 10.1126/science.aay3156.
7
Cancer Screening and Early Detection in the 21 Century.21世纪的癌症筛查与早期检测
Semin Oncol Nurs. 2017 May;33(2):121-128. doi: 10.1016/j.soncn.2017.02.002. Epub 2017 Mar 23.
8
Introduction.引言。
Semin Oncol Nurs. 2017 May;33(2):119-120. doi: 10.1016/j.soncn.2017.02.001. Epub 2017 Mar 23.
9
History, development and future of cancer screening in Australia.澳大利亚癌症筛查的历史、发展与未来。
Public Health Res Pract. 2017 Jul 26;27(3):2731725. doi: 10.17061/phrp2731725.
10
Cancer screening in China: a steep road from evidence to implementation.中国的癌症筛查:从证据到实施的艰难之路。
Lancet Public Health. 2023 Dec;8(12):e996-e1005. doi: 10.1016/S2468-2667(23)00186-X. Epub 2023 Nov 21.

引用本文的文献

1
The Relationship Between Cancer Cognition, Coping Ability and Behavioral Intention of Secondary Cancer Prevention Among Rural Residents in Shandong Province.山东省农村居民癌症认知、应对能力与二级癌症预防行为意向的关系
Risk Manag Healthc Policy. 2025 Aug 18;18:2701-2711. doi: 10.2147/RMHP.S533410. eCollection 2025.
2
Global and China burden of hormone-related cancers and risk factors, 1990-2021: results from the Global Burden of Disease Study 2021.1990 - 2021年全球及中国激素相关癌症负担与风险因素:全球疾病负担研究2021结果
BMC Public Health. 2025 Apr 28;25(1):1566. doi: 10.1186/s12889-025-22768-3.
3
Cost-benefit analysis of p16 immunocytology and liquid-based cytology triage after primary HPV testing for cervical cancer screening in China.
中国宫颈癌筛查中初次HPV检测后p16免疫细胞学和液基细胞学分流的成本效益分析
Infect Agent Cancer. 2025 Apr 18;20(1):26. doi: 10.1186/s13027-025-00642-6.
4
Effect of laxative use and laxative type on colorectal cancer risk: A pooling up analysis and evidence synthesis.泻药使用及泻药类型对结直肠癌风险的影响:一项汇总分析与证据综合
Oncol Lett. 2025 Apr 9;29(6):284. doi: 10.3892/ol.2025.15030. eCollection 2025 Jun.
5
An analysis of the burden of respiratory tract cancers in global, China, the United States and India: findings based on the GBD 2021 database.全球、中国、美国和印度呼吸道癌症负担分析:基于全球疾病负担研究(GBD)2021数据库的结果
BMC Public Health. 2025 Mar 10;25(1):945. doi: 10.1186/s12889-025-21979-y.
6
Lifetime probabilities of developing and dying from cancer in China: comparison with Japan and the United States in 2022.中国癌症发病和死亡的终生概率:与2022年日本和美国的比较。
Sci China Life Sci. 2025 May;68(5):1478-1486. doi: 10.1007/s11427-024-2810-y. Epub 2025 Feb 26.
7
Assessing hemorrhagic risks in combination therapy: implications of angiogenesis inhibitors and immune checkpoint inhibitors.联合治疗中出血风险的评估:血管生成抑制剂和免疫检查点抑制剂的影响
Front Immunol. 2025 Feb 10;16:1527570. doi: 10.3389/fimmu.2025.1527570. eCollection 2025.
8
The burden and long-term trends of breast cancer by different menopausal status in China.中国不同绝经状态下乳腺癌的负担及长期趋势
J Natl Cancer Cent. 2024 Jul 2;4(4):326-334. doi: 10.1016/j.jncc.2024.04.007. eCollection 2024 Dec.
9
Accuracy of breast ultrasound image analysis software in feature analysis: a comparative study with sonographers.乳腺超声图像分析软件在特征分析中的准确性:与超声检查医师的对比研究
Sci Rep. 2024 Dec 28;14(1):30724. doi: 10.1038/s41598-024-79773-6.
10
Comparative analysis of cancer statistics in China and the United States in 2024.2024年中国与美国癌症统计数据的对比分析
Chin Med J (Engl). 2024 Dec 20;137(24):3093-3100. doi: 10.1097/CM9.0000000000003442. Epub 2024 Dec 10.